ANTIBODY-DEPENDENT ENHANCEMENT OF HUMAN IMMUNODEFICIENCY VIRUS TYPE 1 INFECTION
- 1 April 1988
- journal article
- research article
- Published by Elsevier in The Lancet
- Vol. 331 (8589), 790-794
- https://doi.org/10.1016/s0140-6736(88)91657-1
Abstract
No abstract availableThis publication has 22 references indexed in Scilit:
- A Human Immunodeficiency Virus type 1 (HIV-1) infection-enhancing factor in seropositive seraBiochemical and Biophysical Research Communications, 1987
- Immunization against AIDS in humansNature, 1987
- Neutralization of the AIDS Retrovirus by Antibodies to a Recombinant Envelope GlycoproteinScience, 1986
- Role of the HTLV-III/LAV envelope in syncytium formation and cytopathicityNature, 1986
- AIDS Retrovirus Induced Cytopathology: Giant Cell Formation and Involvement of CD4 antigenScience, 1986
- Binding of HTLV-III/LAV to T4 + T Cells by a Complex of the 110K Viral Protein and the T4 MoleculeScience, 1986
- Neutralization of human T-lymphotropic virus type III by sera of AIDS and AIDS-risk patientsNature, 1985
- Major Glycoprotein Antigens That Induce Antibodies in AIDS Patients Are Encoded by HTLV-IIIScience, 1985
- The CD4 (T4) antigen is an essential component of the receptor for the AIDS retrovirusNature, 1984
- Protein A: nature's universal anti-antibodyTrends in Biochemical Sciences, 1982